Related Experiment Videos

Loss of heterozygosity at polymorphic chromosomal loci in patients with malignant melanoma

M Orita1, Y Murakami, K Ishihara

  • 1Oncogene Division, National Cancer Center Research Institute, Tokyo, Japan.

Insights

Loss of heterozygosity in DNA is common in human cancers, suggesting gene inactivation drives cancer development. This study found frequent loss of heterozygosity in malignant melanoma, affecting multiple chromosomes.

Area of Science:

  • Oncology
  • Human Genetics
  • Molecular Biology

Background:

  • Loss of heterozygosity (LOH) at chromosomal loci is a recognized DNA aberration in human cancers.
  • LOH suggests the inactivation of specific genes plays a role in cancer cell genesis.

Purpose of the Study:

  • To investigate the frequency and chromosomal distribution of LOH in malignant melanoma.
  • To determine if specific chromosomal regions are preferentially affected in melanoma.

Main Methods:

  • Analysis of tumor DNA and normal DNA from eight malignant melanoma patients.
  • Utilized 24 polymorphic DNA probes to detect LOH across various chromosomal loci.

Main Results:

  • Detected LOH in three out of eight patients studied.
  • Identified LOH at five distinct loci across four different chromosomes.
  • Observed a relatively high frequency of LOH in malignant melanomas.

Conclusions:

  • The frequency of LOH is significant in malignant melanomas.
  • Chromosomal regions affected by LOH in melanoma are not confined to specific chromosomes.
  • These findings contribute to understanding the genetic instability in melanoma development.

Related Concept Videos